Corxel
PrivateLast Round
Series D
Extension
Jan 22, 2026
Total Funding Raised
$489M
Company Overview
Corxel is a biopharmaceutical company that in-licenses and develops clinical-stage assets to treat cardiometabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Corxel Comparables
Compare Corxel with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhejiang Jixing Auto Parts Co., Ltd. | 97% | |
| Gmax Biopharm | 81% | |
| Sciwind Biosciences | 80% |
For institutional investors. Book with your work email.
Corxel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jan 22, 2026 | ||||
| Series D | Jan 6, 2024 | ||||
| Series C | Sep 1, 2021 | ||||
| Series B | Jul 13, 2021 |
For institutional investors. Book with your work email.
Corxel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hengdian Group Capital | Series D Extension |
| SymBiosis Capital Management | Series D Extension |
| RA Capital Management | Series D Extension |
| TCG Crossover | Series D Extension |
| HBM Healthcare Investments | Series D Extension |
| Adage Capital Management | Series D Extension |
| SilverArc Capital Management | Series D Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2024
$162M round led by Leaps by Bayer and RTW Investments.
For institutional investors. Book with your work email.
Corxel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Corxel's valuation, stock price, and market status.
Is Corxel a public or private company?
Corxel is a private company.
What is the current stock price of Corxel?
Corxel is a private company, so its shares have no public market price. Caplight tracks Corxel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Corxel worth (valuation)?
Valuation information for Corxel is not publicly available.
Can I buy Corxel stock?
Corxel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Corxel's last funding round?
Corxel's most recent funding round was Series D Extension on January 22, 2026.
Who are the main investors in Corxel?
Key investors in Corxel include RTW Investments, Leaps by Bayer.
Will Corxel IPO soon?
No public IPO plans have been announced for Corxel.
How can I track Corxel secondary market activity?
Caplight tracks bids, offers, and trades in Corxel's shares on secondary markets.